{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:03:24Z","timestamp":1793423004407,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 degli Studi di Catania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>P450 oxidoreductase (POR) deficiency (PORD) is characterized by congenital adrenal hyperplasia (CAH) and disorders of sex development (DSD) in both sexes. PORD can also associate with skeletal defects. However, the prevalence of these phenotypes is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>To evaluate the prevalence of CAH, DSD, and infertility of patients with <jats:italic>POR<\/jats:italic> gene pathogenic variants by a systematic review of the literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The literature search was performed through PubMed, MEDLINE, Cochrane, Academic One Files, Google Scholar, and Scopus databases. All studies reporting information on CAH, DSD, testicular adrenal rest tumor (TARTs), and fertility in patients with <jats:italic>POR<\/jats:italic> gene pathogenic variants were included. Finally, the prevalence of abnormal phenotypes was calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 246 articles initially retrieved, only 48 were included for a total of 119 (46 males and 73 females) patients with PORD. We also included the case of a male patient who consulted us for CAH and TARTs but without DSD. This patient, found to be a carrier of combined heterozygous <jats:italic>POR<\/jats:italic> mutation, reached fatherhood spontaneously. All the patients found had CAH. The presence of DSD was found in 65.2%, 82.1%, and 82.1% of patients with compound heterozygosity, homozygosity, or monoallelic heterozygous variants, respectively. The prevalence was significantly higher in females than in males. The prevalence of TARTs in patients with PORD is 2.7%. Only 5 women with PORD became pregnant after assisted reproductive techniques and delivered a healthy baby. Except for the recently reported proband, no other studies focused on male infertility in patients with <jats:italic>POR<\/jats:italic> gene variants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This systematic review of the literature reports the prevalence of CAH, DSD, and TARTs in patients with PORD. The unknown prevalence of <jats:italic>POR<\/jats:italic> gene pathogenetic variants and the paucity of studies investigating fertility do not allow us to establish whether PORD is associated with infertility. Further studies on both women and men are needed to clarify this relationship.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-022-01849-9","type":"journal-article","created":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T12:02:42Z","timestamp":1658059362000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature"],"prefix":"10.1007","volume":"46","author":[{"given":"C.","family":"Gusmano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-8487","authenticated-orcid":false,"given":"R.","family":"Cannarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Crafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"La Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,17]]},"reference":[{"issue":"1","key":"1849_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, Fl\u00fcck CE, Guasti L, Huebner A, Kortmann B et al (2022) Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocrine Rev 43(1):91\u2013159","journal-title":"Endocrine Rev"},{"issue":"1","key":"1849_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03343671","volume":"23","author":"J J\u00e4\u00e4skel\u00e4inen","year":"2000","unstructured":"J\u00e4\u00e4skel\u00e4inen J, Kiekara O, Hippel\u00e4inen M, Voutilainen R (2000) Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency. J Endocrinol Invest 23(1):23\u201327","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"1849_CR3","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1210\/jcem.86.12.8090","volume":"86","author":"NM Stikkelbroeck","year":"2001","unstructured":"Stikkelbroeck NM, Otten BJ, Pasic A, Jager GJ, Sweep CG, Noordam K, Hermus AR (2001) High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86(12):5721\u20135728","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1849_CR4","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2008-1414","volume":"94","author":"N Reisch","year":"2009","unstructured":"Reisch N, Flade L, Scherr M, Rottenkolber M, Pedrosa Gil F, Bidlingmaier M, Wolff H, Schwarz HP, Quinkler M, Beuschlein F, Reincke M (2009) High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab 94(5):1665\u20131670","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1849_CR5","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA et al (2010) United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 95(11):5110\u20135121","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1849_CR6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1530\/EJE-11-0828","volume":"166","author":"H Falhammar","year":"2012","unstructured":"Falhammar H, Nystr\u00f6m HF, Ekstr\u00f6m U, Granberg S, Wedell A, Thor\u00e9n M (2012) Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 166(3):441\u2013449","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1849_CR7","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1210\/jc.2014-4124","volume":"100","author":"C Bouvattier","year":"2015","unstructured":"Bouvattier C, Esterle L, Renoult-Pierre P, de la Perri\u00e8re AB, Illouz F, Kerlan V, Pascal-Vigneron V, Drui D, Christin-Maitre S et al (2015) Clinical outcome, hormonal status, gonadotropic axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. A French National Survey. J Clin Endocrinol Metab 100(6):2303\u20132313","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1849_CR8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/cen.13001","volume":"84","author":"TF King","year":"2016","unstructured":"King TF, Lee MC, Williamson EE, Conway GS (2016) Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Clin Endocrinol (Oxf) 84(6):830\u2013836","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1849_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1530\/EJE-20-1154","volume":"184","author":"J Rohayem","year":"2021","unstructured":"Rohayem J, B\u00e4umer LM, Zitzmann M, Fricke-Otto S, Mohnike K, Gohlke B, Reschke F, Jourdan C, M\u00fcller HL, Dunstheimer D et al (2021) Semen quality and testicular adrenal rest tumour development in 46, XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement. Eur J Endocrinol 184(4):487\u2013501","journal-title":"Eur J Endocrinol"},{"issue":"18","key":"1849_CR10","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.3390\/ijms20184605","volume":"20","author":"F Baronio","year":"2019","unstructured":"Baronio F, Ortolano R, Menab\u00f2 S, Cassio A, Baldazzi L, Di Natale V, Tonti G, Vestrucci B, Balsamo A (2019) 46, XX DSD due to androgen excess in monogenic disorders of steroidogenesis: genetic, biochemical, and clinical features. Int J Mol Sci 20(18):4605","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1849_CR11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jmg.37.1.26","volume":"37","author":"W Reardon","year":"2000","unstructured":"Reardon W, Smith A, Honour JW, Hindmarsh P, Das D, Rumsby G, Nelson I, Malcolm S, Ad\u00e8s L, Sillence D et al (2000) Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet 37(1):26\u201332","journal-title":"J Med Genet"},{"issue":"5","key":"1849_CR12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000488034","volume":"89","author":"ES Baranowski","year":"2018","unstructured":"Baranowski ES, Arlt W, Idkowiak J (2018) Monogenic disorders of adrenal steroidogenesis. Horm Res Paediatr 89(5):292\u2013310","journal-title":"Horm Res Paediatr"},{"key":"1849_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1196\/annals.1336.012","volume":"1061","author":"WL Miller","year":"2005","unstructured":"Miller WL, Huang N, Pandey AV, Fl\u00fcck CE, Agrawal V (2005) P450 oxidoreductase deficiency: a new disorder of steroidogenesis. Ann NY Acad Sci 1061:100\u2013108","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"1849_CR14","doi-asserted-by":"crossref","first-page":"dgaa076","DOI":"10.1210\/clinem\/dgaa076","volume":"105","author":"S Parween","year":"2020","unstructured":"Parween S, Fern\u00e1ndez-Cancio M, Benito-Sanz S, Camats N, Rojas Velazquez MN, L\u00f3pez-Siguero JP, Udhane SS, Kagawa N, Fl\u00fcck CE, Aud\u00ed L et al (2020) Molecular basis of CYP19A1 deficiency in a 46,XX patient with R550W mutation in POR: expanding the PORD phenotype. J Clin Endocrinol Metab 105(4):dgaa076","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1849_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0039-128X(96)00172-9","volume":"62","author":"WL Miller","year":"1997","unstructured":"Miller WL, Auchus RJ, Geller DH (1997) The regulation of 17,20 lyase activity. Steroids 62(1):133\u2013142","journal-title":"Steroids"},{"issue":"2","key":"1849_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1097-201","volume":"17","author":"DH Geller","year":"1997","unstructured":"Geller DH, Auchus RJ, Mendon\u00e7a BB, Miller WL (1997) The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 17(2):201\u2013205","journal-title":"Nat Genet"},{"issue":"6","key":"1849_CR17","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","volume":"273","author":"RJ Auchus","year":"1998","unstructured":"Auchus RJ, Lee TC, Miller WL (1998) Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273(6):3158\u20133165","journal-title":"J Biol Chem"},{"issue":"1","key":"1849_CR18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/mend.13.1.0219","volume":"13","author":"DH Geller","year":"1999","unstructured":"Geller DH, Auchus RJ, Miller WL (1999) P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol Endocrinol 13(1):167\u2013175","journal-title":"Mol Endocrinol"},{"issue":"14","key":"1849_CR19","doi-asserted-by":"crossref","first-page":"13265","DOI":"10.1074\/jbc.M414673200","volume":"280","author":"AV Pandey","year":"2005","unstructured":"Pandey AV, Miller WL (2005) Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem 280(14):13265\u201313271","journal-title":"J Biol Chem"},{"issue":"23","key":"1849_CR20","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","volume":"92","author":"LH Zhang","year":"1995","unstructured":"Zhang LH, Rodriguez H, Ohno S, Miller WL (1995) Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA 92(23):10619\u201310623","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1849_CR21","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1074\/jbc.M209527200","volume":"278","author":"AV Pandey","year":"2003","unstructured":"Pandey AV, Mellon SH, Miller WL (2003) Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. J Biol Chem 278(5):2837\u20132844","journal-title":"J Biol Chem"},{"issue":"5","key":"1849_CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","volume":"76","author":"N Huang","year":"2005","unstructured":"Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, Van Vliet G, Sack J, Fl\u00fcck CE et al (2005) Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76(5):729\u2013749","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1849_CR23","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/EJE-18-0279","volume":"179","author":"WL Miller","year":"2018","unstructured":"Miller WL (2018) Mechanisms in endocrinology: rare defects in adrenal steroidogenesis. Eur J Endocrinol 179(3):R125\u2013R141","journal-title":"Eur J Endocrinol"},{"issue":"9427","key":"1849_CR24","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","volume":"363","author":"W Arlt","year":"2004","unstructured":"Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka Mankiewicz M, Hauffa BP, Malunowicz EM et al (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363(9427):2128\u20132135","journal-title":"Lancet"},{"issue":"3","key":"1849_CR25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","volume":"36","author":"CE Fluck","year":"2004","unstructured":"Fluck CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, Jabs EW, Mendonca BB, Fujieda K, Miller WL (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36(3):228\u2013230","journal-title":"Nat Genet"},{"issue":"4","key":"1849_CR26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.a.30169","volume":"128A","author":"M Adachi","year":"2004","unstructured":"Adachi M, Tachibana K, Asakura Y, Yamamoto T, Hanaki K, Oka A (2004) Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. Am J Med Genet A 128A(4):333\u2013339","journal-title":"Am J Med Genet A"},{"issue":"4","key":"1849_CR27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1081\/ERC-200044174","volume":"30","author":"SA Wudy","year":"2004","unstructured":"Wudy SA, Hartmann MF, Draper N, Stewart PM, Arlt W (2004) A male twin infant with skull deformity and elevated neonatal 17-hydroxyprogesterone: a prismatic case of P450 oxidoreductase deficiency. Endocr Res 30(4):957\u2013964","journal-title":"Endocr Res"},{"issue":"3","key":"1849_CR28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajmg.a.30104","volume":"128A","author":"C Shackleton","year":"2004","unstructured":"Shackleton C, Marcos J, Malunowicz EM, Szarras-Czapnik M, Jira P, Taylor NF, Murphy N, Crushell E, Gottschalk M, Hauffa B et al (2004) Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. Am J Med Genet A 128A(3):223\u2013231","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1849_CR29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/jc.2004-0810","volume":"90","author":"M Fukami","year":"2005","unstructured":"Fukami M, Horikawa R, Nagai T, Tanaka T, Naiki Y, Sato N, Okuyama T, Nakai H, Soneda S, Tachibana K et al (2005) Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and\/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90(1):414\u2013426","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1849_CR30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1203\/01.pdr.0000195825.31504.28","volume":"59","author":"M Fukami","year":"2006","unstructured":"Fukami M, Hasegawa T, Horikawa R, Ohashi T, Nishimura G, Homma K, Ogata T (2006) Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and\/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr Res 59(2):276\u2013280","journal-title":"Pediatr Res"},{"issue":"7","key":"1849_CR31","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2005-2460","volume":"91","author":"K Homma","year":"2006","unstructured":"Homma K, Hasegawa T, Nagai T, Adachi M, Horikawa R, Fujiwara I, Tajima T, Takeda R, Fukami M, Ogata T (2006) Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab 91(7):2643\u20132649","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"1849_CR32","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/ajmg.a.31385","volume":"140A","author":"L Williamson","year":"2006","unstructured":"Williamson L, Arlt W, Shackleton C, Kelley RI, Braddock SR (2006) Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency. Am J Med Genet A 140A(17):1797\u20131803","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1849_CR33","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2008-0051","volume":"93","author":"E Hershkovitz","year":"2008","unstructured":"Hershkovitz E, Parvari R, Wudy SA, Hartmann MF, Gomes LG, Loewental N, Miller WL (2008) Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab 93(9):3584\u20133588","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1849_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BPB.0b013e32830cc35c","volume":"17","author":"N Nakamura","year":"2008","unstructured":"Nakamura N, Adachi M, Machida J, Okuzumi S (2008) Foot anomalies in Antley-Bixler syndrome: three case reports. J Pediatr Orthop B 17(5):241\u2013245","journal-title":"J Pediatr Orthop B"},{"issue":"7","key":"1849_CR35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00431-008-0849-0","volume":"168","author":"JM Ko","year":"2009","unstructured":"Ko JM, Cheon CK, Kim GH, Yoo HW (2009) A case of Antley-Bixler syndrome caused by compound heterozygous mutations of the cytochrome P450 oxidoreductase gene. Eur J Pediatr 168(7):877\u2013880","journal-title":"Eur J Pediatr"},{"issue":"12","key":"1849_CR36","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1210\/jc.2009-1460","volume":"94","author":"T Sahakitrungruang","year":"2009","unstructured":"Sahakitrungruang T, Huang N, Tee MK, Agrawal V, Russell WE, Crock P, Murphy N, Migeon CJ, Miller WL (2009) Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. J Clin Endocrinol Metab 94(12):4992\u20135000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1849_CR37","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2008-2816","volume":"94","author":"M Fukami","year":"2009","unstructured":"Fukami M, Nishimura G, Homma K, Nagai T, Hanaki K, Uematsu A, Ishii T, Numakura C, Sawada H, Nakacho M et al (2009) Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. J Clin Endocrinol Metab 94(5):1723\u20131731","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1849_CR38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/JPEM.2009.22.5.469","volume":"22","author":"S Iijima","year":"2009","unstructured":"Iijima S, Ohishi A, Ohzeki T (2009) Cytochrome P450 oxidoreductase deficiency with Antley\u2013Bixler syndrome: steroidogenic capacities. J Pediatr Endocrinol Metab 22(5):469\u2013475","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"1849_CR39","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1210\/jc.2010-0058","volume":"95","author":"J Idkowiak","year":"2010","unstructured":"Idkowiak J, Malunowicz EM, Dhir V, Reisch N, Szarras-Czapnik M, Holmes DM, Shackleton CH, Davies JD, Hughes IA, Krone N et al (2010) Concomitant mutations in the P450 oxidoreductase and androgen receptor genes presenting with 46, XY disordered sex development and androgenization at adrenarche. J Clin Endocrinol Metab 95(7):3418\u20133427","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1849_CR40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1530\/EJE-10-0764","volume":"163","author":"D Tomalik-Scharte","year":"2010","unstructured":"Tomalik-Scharte D, Maiter D, Kirchheiner J, Ivison HE, Fuhr U, Arlt W (2010) Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. Eur J Endocrinol 163(6):919\u2013924","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1849_CR41","first-page":"59","volume":"16","author":"WM But","year":"2010","unstructured":"But WM, Lo IF, Shek CC, Tse WY, Lam ST (2010) Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency. Hong Kong Med J 16(1):59\u201362","journal-title":"Hong Kong Med J"},{"issue":"3","key":"1849_CR42","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1210\/jc.2010-1607","volume":"96","author":"J Idkowiak","year":"2011","unstructured":"Idkowiak J, O\u2019Riordan S, Reisch N, Malunowicz EM, Collins F, Kerstens MN, K\u00f6hler B, Graul-Neumann LM, Szarras-Czapnik M, Dattani M, Silink M et al (2011) Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab 96(3):E453\u2013E462","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1849_CR43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbrc.2011.08.001","volume":"412","author":"CE Fluck","year":"2011","unstructured":"Fluck CE, Mallet D, Hofer G, Samara-Boustani D, Leger J, Polak M, Morel Y, Pandey AV (2011) Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency. Biochem Biophys Res Commun 412(4):572\u2013577","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1849_CR44","first-page":"281","volume":"69","author":"JC Herkert","year":"2011","unstructured":"Herkert JC, Blaauwwiekel EE, Hoek A, Veenstra-Knol HE, Kema IP, Arlt W, Kerstens MN (2011) A rare cause of congenital adrenal hyperplasia: Antley-Bixler syndrome due to POR deficiency. Neth J Med 69(6):281\u2013283","journal-title":"Neth J Med"},{"issue":"2","key":"1849_CR45","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1210\/jc.2011-0640","volume":"97","author":"N Krone","year":"2012","unstructured":"Krone N, Reisch N, Idkowiak J, Dhir V, Ivison HE, Hughes BA, Rose IT, O\u2019Neil DM, Vijzelaar R, Smith MJ et al (2012) Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab 97(2):E257-267","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1849_CR46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000356857","volume":"23","author":"ES Boia","year":"2014","unstructured":"Boia ES, Popoiu MC, Puiu M, Stanciulescu CM, David VL (2014) Antley-Bixler syndrome: surgical management of ambiguous genitalia\u2014a case report. Med Princ Pract 23(4):384\u2013386","journal-title":"Med Princ Pract"},{"issue":"8","key":"1849_CR47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1590\/S0004-27302012000800020","volume":"56","author":"G Guaragna-Filho","year":"2012","unstructured":"Guaragna-Filho G, Castro CC, Carvalho RR, Coeli FB, Ferraz LF, Petroli RJ, Mello MP, Sewaybricker LE, Lemos-Marini SH, D\u2019Souza-Li LF et al (2012) 46, XX DSD and Antley-Bixler syndrome due to novel mutations in the cytochrome P450 oxidoreductase gene. Arq Bras Endocrinol Metabol 56(8):578\u2013585","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1849_CR48","doi-asserted-by":"crossref","first-page":"bcr2013010251","DOI":"10.1136\/bcr-2013-010251","volume":"2013","author":"D S\u00e1nchez-Garv\u00edn","year":"2013","unstructured":"S\u00e1nchez-Garv\u00edn D, Albaladejo S, Ezquieta B, Corripio R (2013) Disorder of sex development as a diagnostic clue in the first Spanish known newborn with P450 oxidoreductase deficiency. BMJ Case Rep 2013:bcr2013010251","journal-title":"BMJ Case Rep"},{"issue":"6","key":"1849_CR49","doi-asserted-by":"crossref","first-page":"902","DOI":"10.12891\/ceog3172.2016","volume":"43","author":"K Nakanishi","year":"2016","unstructured":"Nakanishi K, Yamashita A, Miyamoto T, Takeguchi R, Furuya A, Matsuo K, Tanahashi Y, Kawamura M, Sengoku K (2016) P450 oxidoreductase deficiency with maternal virilization during pregnancy. Clin Exp Obstet Gynecol 43(6):902\u2013904","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1849_CR50","doi-asserted-by":"crossref","first-page":"882","DOI":"10.12659\/AJCR.895526","volume":"16","author":"E Oldani","year":"2015","unstructured":"Oldani E, Garel C, Bucourt M, Carbillon L (2015) Prenatal diagnosis of Antley-Bixler syndrome and POR deficiency. Am J Case Reports 16:882\u2013885","journal-title":"Am J Case Reports"},{"issue":"2","key":"1849_CR51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14310\/horm.2002.1679","volume":"15","author":"V Koika","year":"2016","unstructured":"Koika V, Armeni AK, Georgopoulos NA (2016) Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency. Hormones (Athens) 15(2):277\u2013282","journal-title":"Hormones (Athens)"},{"issue":"12","key":"1849_CR52","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1210\/jc.2016-1928","volume":"101","author":"S Parween","year":"2016","unstructured":"Parween S, Roucher-Boulez F, Fluck CE, Lienhardt-Roussie A, Mallet D, Morel Y, Pandey AV (2016) P450 oxidoreductase deficiency: loss of activity caused by protein instability from a novel L374H mutation. J Clin Endocrinol Metab 101(12):4789\u20134798","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1849_CR53","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/2359-3997000000213","volume":"60","author":"BD Bonamichi","year":"2016","unstructured":"Bonamichi BD, Santiago SL, Bertola DR, Kim CA, Alonso N, Mendonca BB, Bachega TA, Gomes LG (2016) Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency. Arch Endocrinol Metab 60(5):500\u2013504","journal-title":"Arch Endocrinol Metab"},{"issue":"7","key":"1849_CR54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/bdra.23492","volume":"106","author":"M Tzetis","year":"2016","unstructured":"Tzetis M, Konstantinidou A, Sofocleous C, Kosma K, Mitrakos A, Tzannatos C, KitsiouTzeli S (2016) Compound heterozygosity of a paternal submicroscopic deletion and a maternal missense mutation in POR gene: Antley-Bixler syndrome phenotype in three sibling fetuses. Birth Defects Res A Clin Mol Teratol 106(7):536\u2013541","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"1849_CR55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5734\/JGM.2016.13.1.31","volume":"13","author":"H Woo","year":"2016","unstructured":"Woo H, Ko JM, Shin CH, Yang SW (2016) Two cases of Antley-Bixler syndrome caused by mutations in different genes, FGFR2 and POR. J Genet Med 13(1):31\u201335","journal-title":"J Genet Med"},{"issue":"1","key":"1849_CR56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13048-017-0312-9","volume":"10","author":"Y Bai","year":"2017","unstructured":"Bai Y, Li J, Wang X (2017) Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review. J Ovarian Res 10(1):16","journal-title":"J Ovarian Res"},{"key":"1849_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1393663","author":"T Song","year":"2017","unstructured":"Song T, Wang B, Chen H, Zhu J, Sun H (2017) In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report. Gynecol Endocrinol. https:\/\/doi.org\/10.1080\/09513590.2017.1393663","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1849_CR58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/2230-8210.202031","volume":"21","author":"KS Khadilkar","year":"2017","unstructured":"Khadilkar KS, Jagtap V, Lila A, Bandgar T, Shah NS (2017) Cytochrome P450 oxidoreductase deficiency: novel cause of ambiguity with primary amenorrhea. Indian J Endocrinol Metab 21(2):360\u2013362","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"1849_CR59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3343\/alm.2017.37.6.559","volume":"37","author":"J Oh","year":"2017","unstructured":"Oh J, Song JS, Park JE, Jang SY, Ki CS, Kim DK (2017) A case of Antley-Bixler syndrome with a novel likely pathogenic variant (c.529G>C) in the POR gene. Ann Lab Med 37(6):559\u2013562","journal-title":"Ann Lab Med"},{"issue":"1","key":"1849_CR60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13023-019-1283-2","volume":"14","author":"L Fan","year":"2019","unstructured":"Fan L, Ren X, Song Y, Su C, Fu J, Gong C (2019) Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children. Orphanet J Rare Dis 14(1):299","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1849_CR61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.6065\/apem.1938152.076","volume":"25","author":"Y Lee","year":"2020","unstructured":"Lee Y, Choi JH, Oh A, Kim GH, Park SH, Moon JE, Ko CW, Cheon CK, Yoo HW (2020) Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency. Ann Pediatr Endocrinol Metab 25(2):97\u2013103","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"4","key":"1849_CR62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/humrep\/deaa020","volume":"35","author":"GE Papadakis","year":"2020","unstructured":"Papadakis GE, Dumont A, Bouligand J, Chasseloup F, Raggi A, Catteau-Jonard S, Boute-Benejean O, Pitteloud N, Young J, Dewailly D (2020) Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations. Hum Reprod 35(4):939\u2013949","journal-title":"Hum Reprod"},{"issue":"10","key":"1849_CR63","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s10815-020-01899-z","volume":"37","author":"T Zhang","year":"2020","unstructured":"Zhang T, Li Z, Ren X, Huang B, Zhu G, Yang W, Jin L (2020) Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing\u202f: Overall analysis of a female with POR deficiency. J Assist Reprod Genet 37(10):2503\u20132511","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"1849_CR64","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233942","volume":"13","author":"A Aljabri","year":"2020","unstructured":"Aljabri A, Alnaim F, Alsaleh Y (2020) Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension. BMJ Case Rep 13(9):e233942","journal-title":"BMJ Case Rep"},{"issue":"11","key":"1849_CR65","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fgene.2020.00976","volume":"21","author":"F Song","year":"2020","unstructured":"Song F, Feng S, Shen X, Du M, Yin H, Liu R, Chen X (2020) Next-generation sequencing revealed disease-causing variants in two genes in a patient with combined features of spherocytosis and Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis. Front Genet 21(11):976","journal-title":"Front Genet"},{"issue":"2","key":"1849_CR66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s42000-020-00249-z","volume":"20","author":"E Unal","year":"2021","unstructured":"Unal E, Demiral M, Y\u0131ld\u0131r\u0131m R, Ta\u015f FF, Ceylaner S, \u00d6zbek MN (2021) Cytochrome P450 oxidoreductase deficiency caused by a novel mutation in the POR gene in two siblings: case report and literature review. Hormones (Athens) 20(2):293\u2013298","journal-title":"Hormones (Athens)"},{"issue":"211","key":"1849_CR67","volume":"14","author":"W Wang","year":"2021","unstructured":"Wang W, Han R, Yang Z, Zheng S, Li H, Wan Z, Qi Y, Sun S, Ye L, Ning G (2021) Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 14(211):105899","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1849_CR68","unstructured":"Rakover YT, Admoni O, Elias-Assad G, London S, Barhoum MN, Ludar H, Almagor T, Zehavi Y, Sultan C, Bertalan R et al (2021) The evolving role of whole-exome sequencing in the management of disorders of sex development. Endocr Connect EC-21-0019.R2"},{"issue":"1","key":"1849_CR69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13048-021-00778-0","volume":"14","author":"P Pan","year":"2021","unstructured":"Pan P, Zheng L, Chen X, Huang J, Yang D, Li Y (2021) Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature. J Ovarian Res 14(1):22","journal-title":"J Ovarian Res"},{"issue":"11","key":"1849_CR70","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s40618-021-01546-z","volume":"44","author":"M Karao\u011flan","year":"2021","unstructured":"Karao\u011flan M, Nacarkahya G, Ayta\u00e7 EH, Keskin M (2021) Challenges of CYP21A2 genotyping in children with 21-hydroxylase deficiency: determination of genotype-phenotype correlation using next generation sequencing in Southeastern Anatolia. J Endocrinol Invest 44(11):2395\u20132405","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1849_CR71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40618-021-01648-8","volume":"45","author":"RAA Mahmoud","year":"2022","unstructured":"Mahmoud RAA, Amr NH, Toaima NN, Kamal TM, Elsedfy HH (2022) Genotypic spectrum of 21-hydroxylase deficiency in an endogamous population. J Endocrinol Invest 45(2):347\u2013359","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"1849_CR72","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s40618-021-01527-2","volume":"44","author":"F Pecori Giraldi","year":"2021","unstructured":"Pecori Giraldi F, Einaudi S, Sesta A, Verna F, Messina M, Manieri C, Menegatti E, Ghizzoni L (2021) POR polymorphisms are associated with 21 hydroxylase deficiency. J Endocrinol Invest 44(10):2219\u20132226","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"1849_CR73","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00431-017-3008-7","volume":"176","author":"M Dumic","year":"2017","unstructured":"Dumic M, Duspara V, Grubic Z, Oguic SK, Skrabic V, Kusec V (2017) Testicular adrenal rest tumors in congenital adrenal hyperplasia-cross-sectional study of 51 Croatian male patients. Eur J Pediatr 176(10):1393\u20131404","journal-title":"Eur J Pediatr"},{"issue":"10108","key":"1849_CR74","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","volume":"390","author":"D El-Maouche","year":"2017","unstructured":"El-Maouche D, Arlt W, Merke DP (2017) Congenital adrenal hyperplasia. Lancet 390(10108):2194\u20132210. https:\/\/doi.org\/10.1016\/S0140-6736(17)31431-9 (Epub 2017 May 30. Erratum in: Lancet. 2017 Nov 11;390(10108):2142)","journal-title":"Lancet"},{"key":"1849_CR75","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0015-0282(16)59119-5","volume":"47","author":"AC Bonaccorsi","year":"1987","unstructured":"Bonaccorsi AC, Adler I, Figueiredo JG (1987) Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. Fertil Steril 47:664\u2013670","journal-title":"Fertil Steril"},{"key":"1849_CR76","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1210\/jcem-70-5-1408","volume":"70","author":"RV Clark","year":"1990","unstructured":"Clark RV, Albertson BD, Munabi A et al (1990) Steroidogenic enzyme activities, morphology and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia. J Clin Endocrinol Metab 70:1408\u20131413","journal-title":"J Clin Endocrinol Metab"},{"key":"1849_CR77","first-page":"3070","volume":"86","author":"MS Cabrera","year":"2001","unstructured":"Cabrera MS, Vogiatzi MG, New MI (2001) Long-term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:3070\u20133078","journal-title":"J Clin Endocrinol Metab"},{"key":"1849_CR78","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1210\/jcem.86.12.8090","volume":"86","author":"NMML Stikkelbroeck","year":"2001","unstructured":"Stikkelbroeck NMML, Otten BJ, Pasic A et al (2001) High prevalence of testicular adrenal rest tumours, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:5721\u20135728","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1849_CR79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fertnstert.2018.11.037","volume":"111","author":"LG Gomes","year":"2019","unstructured":"Gomes LG, Bachega TASS, Mendonca BB (2019) Classic congenital adrenal hyperplasia and its impact on reproduction. Fertil Steril 111(1):7\u201312","journal-title":"Fertil Steril"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01849-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01849-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01849-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T15:25:32Z","timestamp":1673623532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01849-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,17]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1849"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01849-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,17]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted at the Division of Endocrinology, Metabolic Diseases and Nutrition and Pediatric Endocrinology of the University-Teaching Hospital Policlinico \u201cG. Rodolico\u201d, University of Catania (Catania, Italy). The protocol was approved by the internal Institutional Review Board. The study has been conducted according to the principles expressed in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from the patient after a full explanation of the purpose and nature of all procedures used.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}